-
-
-
-
-
-
-
Revance Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Form S-3 Revance Therapeutics,
-
-
70,527 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

